The effect of PN200-11O, a novel calcium an tagonist, on the formation of brain edema was examined with rats using a middle cerebral artery (MCA) occlusion model. PN200-110 was effective in preventing the forma tion of brain edema in 6-h ischemia and in 3-h reperfusion following 3-h ischemia, which were cases in which great accumulations of calcium were autoradiographically ob-
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intracranial steal phenomenon (Rasmiissen et al., 1967) . We have tried a novel calcium antagonist (PN200-110) for treatment of ischemic and post ischemic brain tissue in the acute stage and have succeeded in ameliorating ischemic and postisch emic brain edema.
MATERIALS AND METHODS
In this study, we used a middle cerebral artery (MCA) occlusion model with rats (Koizumi et aI., 1986) . This model can easily produce MCA occlusion and reperfu sion by the insertion or removal of the silicon-coated nylon thread, respectively. Its reliability in producing successful strokes is almost complete, without any sei zure activity, and variability in the extent of damage seems to be very little, which includes mainly cortex and lateral caudate perfused by the MCA (Koizumi et aI., 1986 ) and a little larger area than that involved by the MCA occlusion reported by Ta mura et al. (1981) . Male rats of the Wi star strain weighing 250-280 g were anes thetized with ketamine (70 mg/kg i.m.), and the origin of the right MCA was occluded or reperfused by insertion or removal, respectively, of a silicon-coated nylon thread via the common carotid artery. There were four experi mental groups, namely, a sham control group, a 3-h isch emic (1-3) group, a 6-h ischemic (1-6) group, and a group with 3-h ischemia plus 3-h reperfusion (I 3-R3). Each ex perimental group consisted of five rats. Drugs used in this study were physiological saline (vehicle, 1 mllkg) , PN200-110 (0.12 mg/kg/OA ml lactate-Ringer/min, 2 min), and glycerol (OA mllkg/min, 20 min). PN200-110 was kindly donated by Sandoz Co. Ltd. (Basel, Switzerland). The above drugs were intravenously administered when the MCA was occluded in the case of 1-3 and 1-6 or when the MCA was reperfused in the case of I3-R3. At the end of the treatment, the rats were decapitated and the cortex of the center of the occluded MCA territory, that of the surrounding area (area of the ipsilateral anterior cerebral artery), and that of the contralateral MCA area were dis sected and their water contents were measured by the dry weight method. 45Ca autoradiography was performed according to the method of Kato et al. (1987) except in the incubation period, which was 3 h. The calcium con tent of brain was measured according to the method of Ikeda et al. (1986) . Statistical analyses were made by the Student t test. Figure 1 shows typical autoradiograms of the ex perimental groups. In the case of 1-3, 45Ca accumu lated only slightly in the cortex of the ischemic area, while a greater accumulation of 45Ca was found in the ischemic area in the case of 1-6. On the other hand, a marked and diffuse accumulation of 45Ca was observed in the involved area in the case of I3-R3. An excessive influx of extracellular cal cium into cells may either induce cell damage or occur as the result of cell damage. Therefore, the results shown in Fig. 1 suggest the following two possibilities: First, an excessive influx of calcium may aggravate brain cell damage; second, the figure represents only the result of cell damage.
RESULTS AND DISCUSSION
Table 1 simply shows the diminishing effects of PN200-110 on brain edema. This novel calcium an tagonist seems to be effective but not significant in preventing the formation of brain edema in the case of 1-3, but significantly effective in the cases of 1-6 and I3-R3, results that are almost the same as those seen with glycerol treatment. However, the effects of these two drugs may involve different mecha nisms. Glycerol causes an attenuation of brain edema without any inhibition of calcium accumula tion in the occluded MCA area (Tables 1 and 2) . On the other hand, PN200-11O can prevent the forma tion of brain edema with an inhibition of the accu mulation of calcium (Tables 1 and 2) . Glycerol, a hyperosmotic agent, can preserve water in the vas cular lumen against the potential of tissue swelling and may result in an inhibition of brain edema both during and following ischemia.
PN200-110, a derivative of l,4-dihydropyridine, is known as a calcium entry blocker (Miiller Schweinitzer and Neuman, 1983 ) that is hydro phobic and has an affinity for brain tissue. It acts as an inhibitor of the voltage-dependent calcium channel and can improve CBF without the intra- experiments in the following four groups. Con trol, 1-3, 1-6, and 13-R3 represent the cases of sham control, 3-h ischemia, 6-h ischemia, and 3-h ischemia plus 3-h reper fusion, respectively. 45Ca was intravenously injected 3 h be fore decapitation. Left sides in the fi g ures represent the sides treated with the MCA occlusion or reperfusion (corre spondin g to the right hemispheres of rats). Note the diffuse and massive accumUlation of 45Ca in the case of 13-R3. cranial steal phenomenon in the ischemic area (Sauter et al., 1986) . Because this is a model of focal incomplete ischemia (Koizumi et al., 1986) , there are residual blood flows even during isch emia, which are 5.6 ± 2.8, 7. 0 ± 4.2, and 105. 6 ± 23. 0% (mean ± SO, n = 5) of the CBF control value in the center of the MCA involved in the cases of 1-3, 1-6, and I3-R3, respectively. These data were measured in our laboratory by Nagasawa et al. (1987) according to the method of Sakurada et al. (1978) . Therefore, the residual blood flow can supply edema-inducing fluid, extracellular calcium, and PN200-11O. PN200-11O may act to improve the reduced CBF during ischemia and result in an ame- lioration of cell damage, and may finally result in an inhibition of the accumulation of calcium and the formation of brain edema (Tables 1 and 2 ). This means that the inhibition of calcium accumulation during ischemia by PN200-110 represents only the result of the improvement of CBF. However, this concept cannot be applied to the case of reperfu sion. It is well accepted that a recovery of ATP is delayed long after reperfusion (Onodera et aI. , 1986) and that an excessive influx of calcium occurs through voltage-dependent calcium channels during reduction of ATP. Therefore, there are two possibil ities: (a) A massive influx of calcium may occur during the reperfusion period and may result in fur ther damage to brain cells; (b) this influx may occur as the result of other reperfusion injuries such as lipid peroxidation or lactic acidosis (Siesj6, 1981) . PN200-110 may not inhibit the accumulation of cal- cium caused by the above factors in the case of re perfusion if it has only the role of increasing CBF. Therefore, our results suggest that the calcium overload in this model may not simply be the result of cell damage, but may contribute to the aggrava tion of cell damage, especially in the case of reper fusion. The choice of this dose of PN200-11 0 was based on a preliminary study that showed it to be most effective without any side effects. It has recently been reported that calcium entry blocker drugs can improve reduced CBF, EEG activity, and cell me tabolism (Hossmann et aI., 1983; Barnett et aI., 1986; Forsman et aI., 1986) . However, this is the first report on the inhibition of brain edema by a calcium antagonist. Although the drug should be tested with humans, we emphasize the potential benefits of using this type of calcium antagonist for therapy in the acute stage of strokes, especially in cases that may involve calcium-induced cell damage.
